TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
77.20
-5.72 (-6.90%)
At close: Nov 20, 2024, 4:00 PM
77.00
-0.20 (-0.26%)
Pre-market: Nov 21, 2024, 7:41 AM EST
TransMedics Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 28, 2019 | 2018 - 2014 |
| Revenue | 401.09 | 241.62 | 93.46 | 30.26 | 25.64 | 23.6 | Upgrade
|
| Revenue Growth (YoY) | 109.09% | 158.53% | 208.83% | 18.03% | 8.62% | 81.33% | Upgrade
|
| Cost of Revenue | 163.1 | 87.53 | 28.19 | 9.1 | 9 | 9.74 | Upgrade
|
| Gross Profit | 237.99 | 154.09 | 65.27 | 21.16 | 16.64 | 13.86 | Upgrade
|
| Selling, General & Admin | 154.27 | 117.55 | 69.9 | 38.28 | 24.19 | 23.6 | Upgrade
|
| Research & Development | 50.27 | 36.06 | 26.81 | 22.3 | 18.83 | 19.87 | Upgrade
|
| Operating Expenses | 204.54 | 153.61 | 96.71 | 60.59 | 43.02 | 43.47 | Upgrade
|
| Operating Income | 33.46 | 0.49 | -31.44 | -39.43 | -26.38 | -29.6 | Upgrade
|
| Interest Expense | -14.44 | -10.79 | -3.73 | -3.87 | -3.99 | -4.35 | Upgrade
|
| Interest & Investment Income | 14.9 | 12.5 | 0.9 | - | - | 1 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.8 | 0.3 | -1.3 | -1 | 1 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | 0.05 | -0 | 0.12 | 0.65 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | 34.65 | 2.54 | -35.57 | -44.18 | -28.72 | -33.51 | Upgrade
|
| Merger & Restructuring Charges | -2 | -2 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.6 | - | - | - | Upgrade
|
| Pretax Income | 32.65 | -26.67 | -36.17 | -44.18 | -28.72 | -33.51 | Upgrade
|
| Income Tax Expense | 0.02 | -1.64 | 0.07 | 0.04 | 0.03 | 0.04 | Upgrade
|
| Net Income | 32.64 | -25.03 | -36.23 | -44.22 | -28.75 | -33.55 | Upgrade
|
| Net Income to Common | 32.64 | -25.03 | -36.23 | -44.22 | -28.75 | -33.55 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 30 | 28 | 25 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 33 | 30 | 28 | 25 | 14 | Upgrade
|
| Shares Change (YoY) | 6.83% | 10.02% | 7.02% | 11.80% | 73.90% | 945.47% | Upgrade
|
| EPS (Basic) | 0.99 | -0.77 | -1.23 | -1.60 | -1.16 | -2.36 | Upgrade
|
| EPS (Diluted) | 0.94 | -0.77 | -1.23 | -1.60 | -1.16 | -2.36 | Upgrade
|
| Free Cash Flow | -120.51 | -164.88 | -57.72 | -32.38 | -30.72 | -32.45 | Upgrade
|
| Free Cash Flow Per Share | -3.49 | -5.07 | -1.95 | -1.17 | -1.24 | -2.28 | Upgrade
|
| Gross Margin | 59.34% | 63.77% | 69.84% | 69.92% | 64.88% | 58.73% | Upgrade
|
| Operating Margin | 8.34% | 0.20% | -33.64% | -130.29% | -102.91% | -125.42% | Upgrade
|
| Profit Margin | 8.14% | -10.36% | -38.77% | -146.11% | -112.13% | -142.12% | Upgrade
|
| Free Cash Flow Margin | -30.05% | -68.24% | -61.76% | -107.01% | -119.82% | -137.48% | Upgrade
|
| EBITDA | 51.14 | 8.66 | -27.96 | -37.61 | -24.81 | -28.38 | Upgrade
|
| EBITDA Margin | 12.75% | 3.58% | -29.92% | -124.28% | -96.75% | -120.24% | Upgrade
|
| D&A For EBITDA | 17.68 | 8.18 | 3.48 | 1.82 | 1.58 | 1.22 | Upgrade
|
| EBIT | 33.46 | 0.49 | -31.44 | -39.43 | -26.38 | -29.6 | Upgrade
|
| EBIT Margin | 8.34% | 0.20% | -33.64% | -130.29% | -102.91% | -125.42% | Upgrade
|
| Revenue as Reported | 401.09 | 241.62 | 93.46 | 30.26 | 25.64 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.